PDCD1 and neoplasm: To address this issue, in 2022, Wang et al. developed a multifunctional copolymer, BMS202@HZPNPs, which selectively depletes NADPH in tumor cells by targeting BMS202, a small molecule antagonist of PD-1/PD-L1.